Director, Molecular Pharmacology

Eli Lilly Eli Lilly · Pharma · Indianapolis, IN

This role is for a Director of Molecular Pharmacology at Eli Lilly, focusing on designing and executing assays to support drug discovery programs. The role involves developing novel assay platforms, characterizing compound pharmacology, and providing scientific leadership. A key responsibility is to incorporate AI/ML into scientific workflows, though the core function is not AI/ML development itself.

What you'd actually do

  1. Design, develop, and execute molecular pharmacology assays and flow schemes to support drug discovery programs, with emphasis on:– 1) Radioligand binding (competition, saturation, kinetic assays, autoradiography) 2) GPCR internalization and receptor trafficking assays and 3) Imaging-based assays including confocal microscopy and/or high content screening (HCS)
  2. Develop novel, fit-for-purpose assay platforms from the ground up, including assay design, reagent optimization, cell line selection/engineering, and qualification for drug discovery use
  3. Characterize compound pharmacology and mechanisms of action including receptor affinity, selectivity, and functional activity (e.g., G protein signaling, arrestin recruitment, receptor desensitization)
  4. Serve as a recognized expert in their field, providing scientific leadership that shapes program strategy and builds credibility across the organization.
  5. Provide expert scientific guidance that shapes project strategy and improves probability of technical success across multiple programs or therapeutic areas.

Skills

Required

  • PhD with a minimum of 5+ years of drug discovery experience in the pharmaceutical industry (including academic and post‑doc experience); or BS/MS with 10+ years of equivalent experience.
  • Degree in Biochemistry, Biology, Biophysics, Molecular Biology, Pharmacology, or related fields.
  • Demonstrated expertise in molecular pharmacology assay development, including radioligand binding and/or imaging-based modalities
  • Demonstrated drug hunter experience with a track record of advancing discovery programs.
  • Deep scientific background in biochemistry, biophysics, and cell biology to guide compound optimization across modalities.
  • Strong experience leading teams of scientists and achieving cross-disciplinary goals.
  • Hands-on experience with radioligand binding techniques: competition binding, saturation binding, membrane-based assays, and autoradiography support in drug discovery contexts
  • Experience with GPCR internalization and receptor trafficking assays, including one or more of the following: SNAP/CLIP, FRET, luminescence reporters
  • Expertise in receptor pharmacology across multiple target families, with particular emphasis on GPCR downstream signaling
  • Proficiency in confocal microscopy for quantitative cell biology applications: subcellular localization, receptor internalization, endosomal trafficking, colocalization analysis, and live-cell imaging
  • Experience with high content screening (HCS) platforms (e.g., Operetta, Cellomics, IN Cel

Nice to have

  • Team player with a positive, can-do attitude and a commitment to scientific rigor and integrity.

What the JD emphasized

  • recognized authorities in their area of focus
  • seasoned drug hunters
  • strong growth mindset
  • challenge dogma
  • champion breakthrough approaches
  • recognized expert in their field
  • scientific leadership
  • expert scientific guidance
  • state-of-the-art methods and technologies
  • AI/ML into scientific workflows
  • open scientific debate
  • bold, evidence-based decisions
  • mentor and develop diverse scientific talent
  • cross-functional initiatives
  • ONE TEAM, SAME TEAM mindset
  • radical transparency
  • external innovation opportunities
  • Build internal and external networks